ArticleJournal of clinical medicine2026
Patients with Crohn's Disease Achieving Ustekinumab-Induced Remission Are Characterized by Increased Baseline IL-23 Receptor Expression on Lamina Propria Th1 Cells.
Sara Onali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.